Raymond R. Mattingly
Department of Pharmacology
Wayne State University
Detroit
MI 48201
USA
Name/email consistency: high
- The mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor PD184352 (CI-1040) selectively induces apoptosis in malignant schwannoma cell lines. Mattingly, R.R., Kraniak, J.M., Dilworth, J.T., Mathieu, P., Bealmear, B., Nowak, J.E., Benjamins, J.A., Tainsky, M.A., Reiners, J.J. J. Pharmacol. Exp. Ther. (2006)
- Potent suppression of proliferation of a10 vascular smooth muscle cells by combined treatment with lovastatin and 3-allylfarnesol, an inhibitor of protein farnesyltransferase. Mattingly, R.R., Gibbs, R.A., Menard, R.E., Reiners, J.J. J. Pharmacol. Exp. Ther. (2002)
- Down-regulation of growth factor-stimulated MAP kinase signaling in cytotoxic drug-resistant human neuroblastoma cells. Mattingly, R.R., Milstein, M.L., Mirkin, B.L. Cell. Signal. (2001)
- Activation of the Ras-GRF/CDC25Mm exchange factor by lysophosphatidic acid. Mattingly, R.R., Saini, V., Macara, I.G. Cell. Signal. (1999)
- Phosphorylation of serine 916 of Ras-GRF1 contributes to the activation of exchange factor activity by muscarinic receptors. Mattingly, R.R. J. Biol. Chem. (1999)
